The first of our conversations looks at people. We asked Louise Chapman, Head of Marketing & Communications at biostatistics consulting firm Veramed, about the company’s experience of being a B Corp so far and the future goals for the business.
Click the link below to read the Q&A.
This information is necessarily of a general nature and doesn’t constitute legal advice. This is not a substitute for formal legal advice, given in the context of full information under an engagement with Bates Wells.
All content on this page is correct as of March 4, 2021.